Important
#HIV work by
@SimonettiFR and team.
Here's a post by Dr Simonetti on LinkedIn👇
#IDXposts
________________________________________
🦀Time to celebrate🦀.
Our study on
#HIV non-suppressible viremia despite effective ART has been published in Nature Portfolio (Nat Comm).
We studied ~50 PWH on ART with detectable viremia despite no drug resistance and optimal adherence to investigate the frequency of defective proviruses contributing to HIV in plasma.
Three take home messages:
➡️NSV during long-term ART is most likely caused by 5'Leader defective virus released from infected clones, extending previous work from our group and others.
➡️We developed a digital PCR assay allowing to easily Capture 5'Leader Anomalies Without Sequencing (🦀CLAWS🦀). CLAWS is a "drop-off" dPCR assay that can distinguish intact from mutated or deleted Major Splicing Donor (MSD) sequences, where 5'Leader defects converge.
➡️We observed a progressive increase in 5'L-defective RNA in plasma from 1 month on ART (~1%) to long-term ART (~95%), suggesting differential selective pressure for 5'L-defective proviruses.
You can find the paper here
rdcu.be/fm8lU
We hope this study will improve the care of people with HIV with detectable viremia on ART and provide a new tool to study HIV persistence.
This was an incredible collaboration between Johns Hopkins Division of Infectious Diseases, University of Toronto, NIH, and Aarhus University.
Thanks to the Hopkins CFAR, the Ontario HIV Treatment Network and the W.W. Smith Charitable Trust for funding this study.